Quarterly report pursuant to Section 13 or 15(d)

Equity (Details)

v3.24.3
Equity (Details) - USD ($)
$ / shares in Units, $ in Millions
 3 Months Ended 9 Months Ended
Aug. 31, 2020
Mar. 31, 2024
Jun. 30, 2023
Mar. 31, 2023
Sep. 30, 2024
Sep. 30, 2023
Equity [Line Items]            
Gross proceed         $ 29.9 $ 13.8
Net proceeds         $ 29.3 13.4
Grants options (in Shares)         104  
Exercise price (in Dollars per share)         $ 7.28  
Option fair value         $ 0.5  
Expected life         6 years  
Expected volatility minimum         80.50%  
Expected volatility maximum         81.50%  
Expected dividends          
Options to purchase (in Shares)         323,000  
Options exercised (in Shares)         10  
Restricted Stock Units [Member]            
Equity [Line Items]            
Vesting period         3 years  
Weighted average term         10 months 24 days  
Compensation expense         $ 0.4  
Fair value of RSU         1.8  
Unrecognized compensation         $ 0.5  
Minimum [Member]            
Equity [Line Items]            
Discount rate         4.11%  
Maximum [Member]            
Equity [Line Items]            
Discount rate         4.50%  
Stock Options [Member]            
Equity [Line Items]            
Grants options (in Shares)         100,000  
Options exercised (in Shares)         10,000  
Unrecognized compensation expense         $ 10.1  
Weighted average term         3 years  
Compensation expense         $ 3.6 $ 2.4
Stock Options [Member] | Minimum [Member]            
Equity [Line Items]            
Exercise price (in Dollars per share)         $ 7.2  
Vesting period         4 years  
Stock Options [Member] | Maximum [Member]            
Equity [Line Items]            
Exercise price (in Dollars per share)         $ 8.15  
Vesting period         10 years  
Common Stock [Member]            
Equity [Line Items]            
Prospectus value         $ 200.0  
Potential base prospectus         $ 500.0  
Shares of common stock (in Shares)         3,500,000 1,700,000
Options exercised (in Shares)   10,148 44,108 133    
Capital on Demand Sales Agreement [Member]            
Equity [Line Items]            
Prospectus value $ 200.0